Is A a good stock to buy right now?

Based on our 6-factor quantitative model, AGILENT TECHNOLOGIES, INC. (A) receives a "Reduce" rating with a composite score of 42.8/100. It is ranked #2,077 out of 4,446 stocks. Key factor scores: Quality 50/100, Value 42/100, Momentum 34/100. The timing signal is "Neutral". This is quantitative analysis only — not investment advice.

What is the stock rating for A?

AGILENT TECHNOLOGIES, INC. (A) has a "Reduce" rating and 2-star score. The composite score of 42.8 ranks it #2,077 among 4,446 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

AGILENT TECHNOLOGIES, INC. operates in the Technology sector (Measuring And Control Equipment industry) with a market cap of $32.37 billion. It is classified as a large-cap stock.

Does A pay a dividend?

Yes, A pays a dividend with a current yield of 0.86%. For every $1,000 invested, you would receive approximately $8.60 in annual dividend income.

What is A's P/E ratio?

A has a trailing P/E ratio of 27.41x. The Technology sector average is 45.3x. This P/E is in a moderate range relative to the broader market.

A's quality factor score is 50/100. Gross margin: 52.3%. ROE: 21.1% vs sector average -1.4%. High margins suggest pricing power and competitive moats.

How is A valued compared to peers?

A's value factor score is 42/100 (higher = cheaper). Key multiples: P/E 27.4x, EV/EBITDA 24.1x. Valuation is roughly in line with peers.

What is A's debt level?

A's debt-to-equity ratio is 54%. Sector average: 43%. Moderate leverage is normal for established companies.

A has a beta of 1.09, meaning it tracks the market. Stability score: 71/100.

Does A have high short interest?

A's short interest factor score is 32/100 (higher = less short selling). Elevated short interest may indicate bearish sentiment or short squeeze potential.

A Stock Analysis: Reduce (Score 42.8/100) | Blank Capital Research

Data Series	1D	5D	1M	YTD	1Y	3Y	5Y	10Y
A	-0.29%	-0.36%	-0.32%	-15.44%	+15.12%	-	-	-
Industry Proxy XLK	+0.39%	+4.88%	+2.05%	-0.94%	-26.62%	-	-	-
U.S. Market SPY	-0.07%	+3.60%	+0.34%	-0.36%	+29.52%	-	-	-
Alpha vs Market	-0.22%	-3.97%	-0.66%	-15.08%	-14.41%	-	-	-
Alpha vs Sector	-0.67%	-5.24%	-2.37%	-14.50%	+41.74%	-	-	-

Metric	A	Benchmark
P/E Ratio	27.4x	-39%
EV/EBITDA	24.1x	+88%
Price / Book	5.1x

Stock Entity	Score▼	Quality	Value	Momentum	P/E Ratio	ROE	Gross Margin	Net Margin	Rev Growth	D/E Ratio	Market Cap	Compare
VRSN VERISIGN INC/CA	56	79	59	40	30.7x	-41.1%	88.0%	50.6%	8.3%	-87.0x	$23.0B	VS
IHS IHS Holding Ltd	55	42	63	63	-	-616.0%	48.0%	-96.1%	-	365.0x	$2.8B	VS
LHX L3HARRIS TECHNOLOGIES, INC. /DE/	55	50	52	66	37.5x	9.0%	25.5%	8.1%	10.3%	110.0x	$66.1B	VS
ESP ESPEY MFG & ELECTRONICS CORP	53	48	44	71	25.8x	12.8%	29.0%	17.1%	-11.7%	66.0x	$169M	VS
NYAX Nayax Ltd.	52	38	46	78	-	-13.6%	44.6%	-1.8%	-	30.0x	$2.2B	VS
ESE ESCO TECHNOLOGIES INC	52	49	40	69	65.6x	7.4%	40.8%	10.4%	16.3%	9.0x	$7.6B	VS
INTT INTEST CORP	52	50	32	72	-	-3.2%	43.1%	-3.1%	-22.8%	46.0x	$179M	VS
KARO Karooooo Ltd.	49	50	72	53	-	117.1%	69.5%	20.3%	-	10.0x	$1.6B	VS
MTC MMTec, Inc.	47	32	40	96	-	-1,370.8%	81.6%	-4,879.7%	-	120.0x	$136M	VS
CCLD CareCloud, Inc.	47	38	71	60	12.4x	18.5%	48.0%	9.6%	10.6%	47.0x	$154M	VS
A AGILENT TECHNOLOGIES, INC.	43	50	42	34	27.4x	21.1%	52.3%	17.0%	13.9%	54.0x	$32.4B

Key Ratio	TTM	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin %	0.5%	0.5%	0.5%	0.5%	0.5%	0.5%	0.5%	0.5%	0.5%	0.5%	0.5%
Operating Margin %	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%
EBITDA Margin %	0.2%	0.2%	0.2%	0.3%	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%
Net Margin %	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%	0.2%	0.1%	0.2%	0.1%	0.2%
FCF Margin %	-8.7%	-	-	21.1%	-	-	-	15.0%	16.8%	18.5%	15.9%
ROE %	-638.0%	-165.8%	-576.5%	0.2%	0.2%	0.2%	0.2%	0.1%	0.2%	0.1%	0.1%
ROA %	0.1%	0.0%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%	0.1%
ROIC %	0.4%	9.7%	41.4%	14.8%	12.4%	15.9%	19.7%	11.5%	12.9%	17.8%	16.0%

Key Ratio

TTM

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

Gross Margin %

0.5%

Operating Margin %

0.2%

EBITDA Margin %

0.2%

0.3%

0.2%

Net Margin %

0.2%

0.1%

0.2%

0.1%

0.2%

FCF Margin %

-8.7%

21.1%

15.0%

16.8%

18.5%

15.9%

ROE %

-638.0%

-165.8%

-576.5%

0.2%

0.1%

0.2%

0.1%

ROA %

0.1%

0.0%

0.1%

0.0%

0.1%

ROIC %

0.4%

9.7%

41.4%

14.8%

12.4%

15.9%

19.7%

11.5%

12.9%

17.8%

16.0%

Line Item	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
	$6.9B	$6.9B	$6.5B	$6.8B	$6.8B	$6.3B	$5.3B	$5.2B	$4.9B	$4.5B	$4.2B	$4.0B
	—	$3.3B	—	$3.4B	$3.1B	$2.9B	—	—	—	—	—	—
	$3.6B	$3.6B	$3.5B	$3.5B	$3.7B	$3.4B	$2.8B	$2.8B	$2.7B	$2.4B	$2.2B	$2.0B
Gross Margin	52.3%	52.4%	54.3%	50.7%	54.4%	53.9%	53.1%	54.3%	54.5%	53.6%	52.3%	50.5%
	—	$1.7B	—	$1.6B	$1.6B	$1.6B	—	—	—	—	—	—
Research & Development	—	$455M	$479M	$481M	$467M	$441M	$495M	$404M	$385M	$339M	$329M	$330M
Depreciation	—	—	$257M	—	—	—	$308M	$238M	$210M	$212M	$246M	$253M
Total Operating Expenses	—	$2.2B	—	$2.1B	$2.1B	$2.1B	—	—	—	—	—	—
	$1.4B	$1.5B	$1.5B	$1.4B	$1.6B	$1.3B	$846M	$941M	$928M	$841M	$615M	$522M
EBIT	$1.4B	$1.5B	$1.5B	$1.4B	$1.6B	$1.3B	$846M	$941M	$928M	$841M	$615M	$522M
EBITDA	$1.5B	$1.5B	$1.8B	$1.4B	$1.6B	$1.3B	$1.2B	$1.2B	$1.2B	$1.1B	$851M	$792M
Operating Margin	20.2%	21.3%	22.9%	19.8%	23.6%	21.3%	15.8%	18.2%	18.4%	18.1%	14.6%	12.9%
EBITDA Margin	21.3%	21.3%	27.6%	19.8%	23.6%	21.3%	22.9%	23.1%	24.3%	24.0%	20.3%	19.6%
	—	$112M	$96M	$95M	$84M	$81M	$78M	$74M	$75M	$79M	$72M	$66M
	—	$1.4B	—	$1.3B	$1.5B	$1.4B	—	—	—	—	—	—
Income Tax Expense	—	$132M	$232M	$99M	$250M	$150M	$123M	-$152M	$630M	$119M	$82M	$42M
	$1.2B	$1.3B	$1.3B	$1.2B	$1.3B	$1.2B	$719M	$1.1B	$316M	$684M	$462M	$401M
Net Margin	17.0%	18.8%	19.8%	18.1%	18.3%	19.1%	13.5%	20.7%	6.4%	15.3%	11.0%	9.9%
	$1.08	$4.59	$4.44	$4.22	$4.19	$3.98	$2.33	$3.41	$0.98	$2.12	$1.42	$1.20
Diluted EPS	$1.08	$4.57	$4.44	$4.19	$4.18	$3.94	$2.33	$3.41	$0.98	$2.12	$1.42	$1.20
Weighted Avg Basic	—	284M	—	294M	299M	304M	—	—	—	—	—	—
Weighted Avg Diluted	—	285M	—	296M	300M	307M	—	—	—	—	—	—

Line Item

TTM

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

$6.9B

$6.5B

$6.8B

$6.3B

$5.3B

$5.2B

$4.9B

$4.5B

$4.2B

$4.0B

—

$3.3B

—

$3.4B

$3.1B

$2.9B

—

$3.6B

$3.5B

$3.7B

$3.4B

$2.8B

$2.7B

$2.4B

$2.2B

$2.0B

Gross Margin

52.3%

52.4%

54.3%

50.7%

54.4%

53.9%

53.1%

54.3%

54.5%

53.6%

52.3%

50.5%

—

$1.7B

—

$1.6B

—

Research & Development

—

$455M

$479M

$481M

$467M

$441M

$495M

$404M

$385M

$339M

$329M

$330M

Depreciation

—

$257M

—

$308M

$238M

$210M

$212M

$246M

$253M

Total Operating Expenses

—

$2.2B

—

$2.1B

—

$1.4B

$1.5B

$1.4B

$1.6B

$1.3B

$846M

$941M

$928M

$841M

$615M

$522M

EBIT

$1.4B

$1.5B

$1.4B

$1.6B

$1.3B

$846M

$941M

$928M

$841M

$615M

$522M

EBITDA

$1.5B

$1.8B

$1.4B

$1.6B

$1.3B

$1.2B

$1.1B

$851M

$792M

Operating Margin

20.2%

21.3%

22.9%

19.8%

23.6%

21.3%

15.8%

18.2%

18.4%

18.1%

14.6%

12.9%

EBITDA Margin

21.3%

27.6%

19.8%

23.6%

21.3%

22.9%

23.1%

24.3%

24.0%

20.3%

19.6%

—

$112M

$96M

$95M

$84M

$81M

$78M

$74M

$75M

$79M

$72M

$66M

—

$1.4B

—

$1.3B

$1.5B

$1.4B

—

Income Tax Expense

—

$132M

$232M

$99M

$250M

$150M

$123M

-$152M

$630M

$119M

$82M

$42M

$1.2B

$1.3B

$1.2B

$1.3B

$1.2B

$719M

$1.1B

$316M

$684M

$462M

$401M

Net Margin

17.0%

18.8%

19.8%

18.1%

18.3%

19.1%

13.5%

20.7%

6.4%

15.3%

11.0%

9.9%

$1.08

$4.59

$4.44

$4.22

$4.19

$3.98

$2.33

$3.41

$0.98

$2.12

$1.42

$1.20

Diluted EPS

$1.08

$4.57

$4.44

$4.19

$4.18

$3.94

$2.33

$3.41

$0.98

$2.12

$1.42

$1.20

Weighted Avg Basic

—

284M

—

294M

299M

304M

—

Weighted Avg Diluted

—

285M

—

296M

300M

307M

—

AGILENT TECHNOLOGIES, INC. (A) Stock Analysis — April 2026 Rating, Price, and Forecast

Last updated: April 2026

Company Overview — What Does AGILENT TECHNOLOGIES, INC. Do?

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. AGILENT TECHNOLOGIES, INC. (A) is classified as a large-cap stock in the Technology sector, specifically within the Measuring And Control Equipment industry. The company is led by CEO Michael R. McMullen and employs approximately 18,100 people, headquartered in Santa Clara, California. With a market capitalization of $32.4B, A is one of the prominent companies in the Technology sector.

AGILENT TECHNOLOGIES, INC. (A) Stock Rating — Reduce (April 2026)

As of April 2026, AGILENT TECHNOLOGIES, INC. receives a Reduce rating with a composite score of 42.8/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.A ranks #2,077 out of 4,446 stocks in our coverage universe. Within the Technology sector, AGILENT TECHNOLOGIES, INC. ranks #225 of 584 stocks, placing it in the upper half of its Technology peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

A Stock Price and 52-Week Range

AGILENT TECHNOLOGIES, INC. (A) currently trades at $115.06. The stock lost $0.33 (0.3%) in the most recent trading session. The 52-week high for A is $160.27, which means the stock is currently trading -28.2% from its annual peak. The 52-week low is $96.43, putting the stock 19.3% above its annual trough. Recent trading volume was 1.0M shares, reflecting moderate market activity.

Is A Overvalued or Undervalued? — Valuation Analysis

AGILENT TECHNOLOGIES, INC. (A) carries a value factor score of 42/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 27.41x, compared to the Technology sector average of 45.27x — a discount of 39%. The price-to-book ratio stands at 5.10x, versus the sector average of 3.16x. The price-to-sales ratio is 4.67x, compared to 1.06x for the average Technology stock. On an enterprise value basis, A trades at 24.05x EV/EBITDA, versus 12.79x for the sector.

Overall, A's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.

AGILENT TECHNOLOGIES, INC. Profitability — ROE, Margins, and Quality Score

AGILENT TECHNOLOGIES, INC. (A) earns a quality factor score of 50/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 21.1%, compared to the Technology sector average of -1.4%, which demonstrates strong shareholder value creation. Return on assets (ROA) comes in at 9.2% versus the sector average of -1.0%.

On a margin basis, AGILENT TECHNOLOGIES, INC. reports gross margins of 52.3%, compared to 50.9% for the sector. The operating margin is 20.2% (sector: -0.5%). Net profit margin stands at 17.0%, versus -1.5% for the average Technology stock. Revenue growth is running at 13.9% on a trailing basis, compared to 14.2% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.

A Debt, Balance Sheet, and Financial Health

AGILENT TECHNOLOGIES, INC. has a debt-to-equity ratio of 54.0%, compared to the Technology sector average of 43.0%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. The current ratio is 2.07x, indicating strong short-term liquidity. Total debt on the balance sheet is $3.05B. Cash and equivalents stand at $1.79B.

A has a beta of 1.09, meaning it is roughly in line with the broader market in terms of price volatility. The stability factor score for AGILENT TECHNOLOGIES, INC. is 71/100, indicating low-volatility characteristics and consistent price behavior that appeals to risk-averse investors.

AGILENT TECHNOLOGIES, INC. Revenue and Earnings History — Quarterly Trend

In TTM 2026, AGILENT TECHNOLOGIES, INC. reported revenue of $6.88B and earnings per share (EPS) of $1.08. Net income for the quarter was $1.17B. Gross margin was 52.3%. Operating income came in at $1.39B.

In Q1 2026, AGILENT TECHNOLOGIES, INC. reported revenue of $1.80B and earnings per share (EPS) of $1.08. Net income for the quarter was $305M. Gross margin was 52.6%. Revenue grew 7.0% year-over-year compared to Q1 2025. Operating income came in at $353M.

In FY 2025, AGILENT TECHNOLOGIES, INC. reported revenue of $6.95B and earnings per share (EPS) of $4.59. Net income for the quarter was $1.30B. Gross margin was 52.4%. Revenue grew 6.7% year-over-year compared to FY 2024. Operating income came in at $1.48B.

In Q3 2025, AGILENT TECHNOLOGIES, INC. reported revenue of $1.74B and earnings per share (EPS) of $1.18. Net income for the quarter was $336M. Gross margin was 51.1%. Revenue grew 10.1% year-over-year compared to Q3 2024. Operating income came in at $360M.

Over the past 8 quarters, AGILENT TECHNOLOGIES, INC. has demonstrated a growth trajectory, with revenue expanding from $1.58B to $6.88B. Investors analyzing A stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

A Dividend Yield and Income Analysis

AGILENT TECHNOLOGIES, INC. (A) currently pays a dividend yield of 0.9%. At this yield, a $10,000 investment in A stock would generate approximately $$86.00 in annual dividend income. With a net margin of 17.0%, the dividend appears well-covered by earnings, suggesting sustainable payouts going forward.

A Momentum and Technical Analysis Profile

AGILENT TECHNOLOGIES, INC. (A) has a momentum factor score of 34/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 28/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 32/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.

A vs Competitors — Technology Sector Ranking and Peer Comparison

Within the Technology sector, AGILENT TECHNOLOGIES, INC. (A) ranks #225 out of 584 stocks based on the Blank Capital composite score. This places A in the upper half of all Technology stocks in our coverage universe. Key competitors and sector peers include IHS Holding Ltd (IHS) with a score of 55.0/100, VERISIGN INC/CA (VRSN) with a score of 56.0/100, ESCO TECHNOLOGIES INC (ESE) with a score of 51.7/100, CareCloud, Inc. (CCLD) with a score of 46.9/100, and MMTec, Inc. (MTC) with a score of 47.4/100.

Comparing A against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full A vs S&P 500 (SPY) comparison to assess how AGILENT TECHNOLOGIES, INC. stacks up against the broader market across all factor dimensions.

A Next Earnings Date

No upcoming earnings date has been announced for AGILENT TECHNOLOGIES, INC. (A) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy A? — Investment Thesis Summary

The quantitative profile for AGILENT TECHNOLOGIES, INC. suggests caution. Momentum is weak at 34/100, a headwind for near-term performance. Low volatility (stability score 71/100) reduces downside risk.

In summary, AGILENT TECHNOLOGIES, INC. (A) earns a Reduce rating with a composite score of 42.8/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on A stock.

Related Resources for A Investors

Explore more research and tools: A vs S&P 500 comparison, top Technology stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare A head-to-head with peers: A vs IHS, A vs VRSN, A vs ESE.

Business quality

Valuation edge

Market alpha

Unlock Investment Thesis

Unlock Performance & Technicals

Unlock Valuation Tools

Institutional peer matrix

Dispersion: efficiency vs. valuation

Lateral intelligence network

Unlock Financial Statements

Unlock Ownership & Management

Intelligence Feed

Thermo Fisher Partnership With PRECISE Puts Proteomics At Core Of TMO Story

How New Diagnostic Win and Patent Loss Will Impact Agilent Technologies (A) Investors

Flow Cytometry Market Set to Surpass USD 12.19 Billion by 2035, Driven by Rising Demand for Precision Diagnostics – SNS Insider

Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications

Here's How Much a $1000 Investment in Keysight Made 10 Years Ago Would Be Worth Today

Unlock Earnings Transcripts

Institutional Intelligence FAQ

Related Research & Tools

Related Technology Stocks

AGILENT TECHNOLOGIES, INC. (A) Stock Analysis — April 2026 Rating, Price, and Forecast

Company Overview — What Does AGILENT TECHNOLOGIES, INC. Do?

AGILENT TECHNOLOGIES, INC. (A) Stock Rating — Reduce (April 2026)

A Stock Price and 52-Week Range

Is A Overvalued or Undervalued? — Valuation Analysis

AGILENT TECHNOLOGIES, INC. Profitability — ROE, Margins, and Quality Score

A Debt, Balance Sheet, and Financial Health

AGILENT TECHNOLOGIES, INC. Revenue and Earnings History — Quarterly Trend

A Dividend Yield and Income Analysis

A Momentum and Technical Analysis Profile

A vs Competitors — Technology Sector Ranking and Peer Comparison

A Next Earnings Date

Should You Buy A? — Investment Thesis Summary

Related Resources for A Investors

Comments

Institutional Benchmarks

Related research

Get alerted on rating changes

Intelligence Feed

Thermo Fisher Partnership With PRECISE Puts Proteomics At Core Of TMO Story

How New Diagnostic Win and Patent Loss Will Impact Agilent Technologies (A) Investors

Flow Cytometry Market Set to Surpass USD 12.19 Billion by 2035, Driven by Rising Demand for Precision Diagnostics – SNS Insider

Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications

Here's How Much a $1000 Investment in Keysight Made 10 Years Ago Would Be Worth Today